Clin2
NCT06568640Possibly a fitRecruiting

Adrenal artery treatment for hard-to-control high blood pressure

Essential Hypertension

Part of Heart & circulation clinical trials.

This study tests a minimally invasive procedure called superselective adrenal arterial embolization for people whose high blood pressure is hard to control with medications. The goal is to see if this treatment can safely lower blood pressure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have high blood pressure that doesn't get better with at least three medications (including a water pill).
  • Your average office blood pressure (top number) is 150 mmHg or higher.
  • Your adrenal hormone levels (aldosterone and renin) are not too low.
  • You do not have serious health problems like recent stroke, heart attack, heart failure, severe kidney disease, or a large adrenal tumor.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07051811Recruiting
Blood vessel treatment for hard-to-control high blood pressure

This trial tests a new device that uses ultrasound to treat nerves in the kidney arteries that may be overactive and raising your blood pressure. It's for people whose blood pressure stays high despite taking at least two medications.

Beijing, Beijing Municipality
NCT05561361Recruiting
Test treatment for primary aldosteronism and blood vessel function

This trial studies whether a specific treatment (related to spironolactone/aldosterone support) can improve how well your blood vessels work in people with primary aldosteronism. It may help reduce blood pressure risk by improving blood vessel health.

Nanchang
NCT05501080Recruiting
Testing a hormone treatment to improve heart changes in PA

This trial tests whether a treatment called SAAE can improve “ventricular remodeling,” meaning changes in the heart muscle, in people with primary aldosteronism (PA). It may help the heart work more efficiently by targeting the cause of high aldosterone levels.

Nanchang
NCT06513676Recruiting
Adrenal artery treatment for aldosteronism study

This study tests a procedure that blocks tiny arteries in the adrenal gland to treat high blood pressure and low potassium caused by aldosteronism. It may be an option if you cannot take medications or cannot have surgery.

Ürümqi, Xinjiang
NCT06228677Recruiting
Catecholamine levels during adrenal artery embolization

This trial measures hormone levels in blood during a procedure to treat high blood pressure caused by an adrenal gland problem. It may help doctors understand how the body responds during treatment.

Chengdu, Sichuan
NCT07328230Recruiting
New procedure vs standard pill for adrenal-related high blood pressure

This study tests if a new procedure (blocking tiny adrenal arteries) works as well as a standard pill (spironolactone) for lowering high blood pressure caused by too much aldosterone from both adrenal glands. It is designed for people whose high blood pressure is due to idiopathic hyperaldosteronism.

Beijing, Beijing Municipality

Hear when a new Essential Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.